PTCT
PTC Therapeutics Inc
NASDAQ: PTCT · HEALTHCARE · BIOTECHNOLOGY
$65.06
+0.79% today
Updated 2026-04-30
Market cap
$5.83B
P/E ratio
8.19
P/S ratio
3.37x
EPS (TTM)
$8.58
Dividend yield
—
52W range
$36 – $88
Volume
1.2M
PTC Therapeutics Inc (PTCT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2004 | 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.61M | $4.97M | $98.96M | $28.78M | $31.33M | $22.96M | $36.77M | $82.70M | $194.39M | $264.73M | $306.98M | $380.77M | $538.59M | $698.80M | $937.82M | $806.78M | $1.73B |
| Revenue growth (YoY) | — | +209.3% | +1892.4% | -70.9% | +8.9% | -26.7% | +60.1% | +124.9% | +135.0% | +36.2% | +16.0% | +24.0% | +41.4% | +29.7% | +34.2% | -14.0% | +114.5% |
| Cost of revenue | $24.66M | $27.60M | $71.96M | $-5.17M | $54.88M | $79.84M | $121.82M | $117.63M | $4.58M | $12.67M | $12.13M | $18.94M | $32.33M | $44.68M | $65.49M | $57.40M | $71.75M |
| Gross profit | — | — | $98.96M | $33.95M | $-23.55M | $-56.88M | $36.77M | $82.70M | $189.81M | $252.06M | $294.85M | $361.82M | $506.26M | $654.12M | $872.34M | $749.38M | $1.66B |
| Gross margin | 0.0% | 0.0% | 100.0% | 118.0% | -75.2% | -247.7% | 100.0% | 100.0% | 97.6% | 95.2% | 96.0% | 95.0% | 94.0% | 93.6% | 93.0% | 92.9% | 95.9% |
| R&D | $20.07M | $21.12M | $58.68M | $46.14M | $54.88M | $79.84M | $121.82M | $117.63M | $117.46M | $171.98M | $257.45M | $477.64M | $540.68M | $651.50M | $666.56M | $534.48M | $455.25M |
| SG&A | — | — | $16.15M | $14.62M | $25.22M | $44.82M | $82.08M | $97.13M | $121.27M | $153.55M | $202.54M | $245.16M | $285.27M | $300.10M | $348.97M | $300.91M | $347.14M |
| Operating income | — | — | $30.58M | $-26.81M | $-45.40M | $-99.41M | $-167.13M | $-132.06M | $-64.29M | $-115.69M | $-241.16M | $-431.77M | $-374.44M | $-447.41M | $-439.50M | $-302.57M | $856.51M |
| Operating margin | 0.0% | 0.0% | 30.9% | -93.2% | -144.9% | -432.9% | -454.6% | -159.7% | -33.1% | -43.7% | -78.6% | -113.4% | -69.5% | -64.0% | -46.9% | -37.5% | 49.5% |
| EBITDA | — | — | $33.45M | $-24.10M | $-43.00M | $-97.18M | $-164.25M | $-128.77M | $-46.61M | $-89.47M | $-195.25M | $-303.09M | $-368.18M | $-367.78M | $-330.34M | $-120.46M | $887.66M |
| EBITDA margin | 0.0% | 0.0% | 33.8% | -83.8% | -137.3% | -423.2% | -446.8% | -155.7% | -24.0% | -33.8% | -63.6% | -79.6% | -68.4% | -52.6% | -35.2% | -14.9% | 51.3% |
| EBIT | — | — | $30.58M | $-26.81M | $-45.40M | $-99.41M | $-167.13M | $-132.06M | $-64.29M | $-115.56M | $-227.44M | $-346.58M | $-432.32M | $-496.62M | $-566.93M | $-196.13M | $848.85M |
| Interest expense | $0.00 | $0.00 | $2.44M | $1.21M | $6.08M | $1.18M | $2.37M | $8.28M | $12.09M | $12.55M | $12.49M | $56.35M | $86.02M | $90.87M | $129.18M | $166.99M | $152.23M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | — | $30.90M | $-26.24M | $-51.57M | $-93.75M | $-170.45M | $-142.11M | $-79.00M | $-128.08M | $-251.58M | $-438.16M | $-523.90M | $-559.02M | $-626.60M | $-363.30M | $682.64M |
| Net income growth (YoY) | — | — | — | -184.9% | -96.6% | -81.8% | -81.8% | +16.6% | +44.4% | -62.1% | -96.4% | -74.2% | -19.6% | -6.7% | -12.1% | +42.0% | +287.9% |
| Profit margin | 0.0% | 0.0% | 31.2% | -91.2% | -164.6% | -408.3% | -463.6% | -171.8% | -40.6% | -48.4% | -82.0% | -115.1% | -97.3% | -80.0% | -66.8% | -45.0% | 39.4% |